Updated at 12:17 pm EST Pfizer (PFE) – Get Pfizer Inc. Report shares slumped lower Thursday amid investor concern over potential litigation linked to the popular, but now-discontinued, heartbur...
Tag: Drug Approvals
Biotech Stocks Are Cheap. Is It Time for Blockbuster M&A?
Biotech stocks took a beating over the past 12 months, but their cheap valuations could be good entry points for investors, experts say. It could also open them up for opportunities to be acquired or ...
Biotech Stocks Could Rally – TheStreet
Biotech stocks took a beating over the past 12 months, but their cheap valuations could be good entry points for investors, experts say. The outlook for biotech stocks is positive in part because the ...
Moderna Stock Surges On Q4 Earnings Beat, 2022 Vaccine Sales Boost
Updated at 10:06 am EST Moderna (MRNA) – Get Moderna, Inc. Report shares surged Thursday after the drugmaker posted must stronger-than-expected fourth quarter earnings, while boosting its full-...